Post-vaccination HPV prevalence, genotype distribution, and associated factors among vaccinated women in China: A cross-sectional study.

Hum Vaccin Immunother · 2026 · PMC13371873 · PMID 42421198

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

might not be significantno p-value reported

Additionally, the cross-protection of HPV vaccine might not be significant in this study, which was consistent with previous clinical trials and surveillance studies, showing a genotype-restricted characteristics. 29 , 30 For instance, the cross-protection was only observed for HPV31 and HPV33 among women vaccinated with 2vHPV, and no trend for protection against HPV45, H

also in 673 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.